Literature DB >> 17200283

The limits of viability and the uncertainty of neuroprotection: challenges in optimizing outcomes in extreme prematurity.

Michael E Msall1.   

Abstract

Mesh:

Year:  2007        PMID: 17200283     DOI: 10.1542/peds.2006-3095

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  2 in total

1.  Positive screening for autism in ex-preterm infants: prevalence and risk factors.

Authors:  Catherine Limperopoulos; Haim Bassan; Nancy R Sullivan; Janet S Soul; Richard L Robertson; Marianne Moore; Steven A Ringer; Joseph J Volpe; Adré J du Plessis
Journal:  Pediatrics       Date:  2008-04       Impact factor: 7.124

2.  Deaths in a Modern Cohort of Extremely Preterm Infants From the Preterm Erythropoietin Neuroprotection Trial.

Authors:  Sandra E Juul; Thomas R Wood; Bryan A Comstock; Krystle Perez; Semsa Gogcu; Mihai Puia-Dumitrescu; Sara Berkelhamer; Patrick J Heagerty
Journal:  JAMA Netw Open       Date:  2022-02-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.